<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis - Andrade‐Castellanos, CA - 2016 | Cochrane Library</title> <meta content="Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis - Andrade‐Castellanos, CA - 2016 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011281.pub2/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis - Andrade‐Castellanos, CA - 2016 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011281.pub2/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011281.pub2" name="dc.identifier" scheme="DOI"/> <meta content="Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis" name="citation_title"/> <meta content="Carlos A Andrade‐Castellanos" name="citation_author"/> <meta content='Hospital Civil de Guadalajara "Dr. Juan I. Menchaca"' name="citation_author_institution"/> <meta content="caandrade@hcg.gob.mx" name="citation_author_email"/> <meta content="Luis Enrique Colunga‐Lozano" name="citation_author"/> <meta content='Hospital Civil de Guadalajara "Fray Antonio Alcalde"' name="citation_author_institution"/> <meta content="Netzahualpilli Delgado‐Figueroa" name="citation_author"/> <meta content="Hospital Civil de Guadalajara Dr. Juan I. Menchaca" name="citation_author_institution"/> <meta content="Daniel A Gonzalez‐Padilla" name="citation_author"/> <meta content="Hospital Universitario 12 de Octubre" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="1" name="citation_issue"/> <meta content="10.1002/14651858.CD011281.pub2" name="citation_doi"/> <meta content="2016" name="citation_date"/> <meta content="2016/01/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011281.pub2/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011281.pub2/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011281.pub2/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Diabetic Ketoacidosis [*drug therapy]; Hypoglycemic Agents [adverse effects, *therapeutic use]; Injections, Subcutaneous; Insulin [therapeutic use]; Insulin Aspart [therapeutic use]; Insulin Lispro [therapeutic use]; Insulin, Short‐Acting [adverse effects, *therapeutic use]; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011281.pub2&amp;doi=10.1002/14651858.CD011281.pub2&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="uQyIsxpV";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011281\x2epub2\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011281\x2epub2\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","hr","th","fa","zh_HANS"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011281.pub2",title:"Subcutaneous rapid\\u2010acting insulin analogues for diabetic ketoacidosis",firstPublishedDate:"Jan 21, 2016 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Metabolic and Endocrine Disorders Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011281.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011281.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011281.pub2/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011281.pub2/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011281.pub2%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011281.PUB2" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Laienverständliche Zusammenfassung&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Conclusiones de los autores&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Antecedentes&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Objetivos&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Métodos&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Discusión&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011281.pub2/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011281.PUB2" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011281.pub2/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011281.pub2/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>11705 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011281.pub2" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-abs-0003"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0103"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0029"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0030"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0036"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0037"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0064"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-sec-0097"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/appendices#CD011281-sec-0108"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/table_n/CD011281StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/table_n/CD011281StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2016 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#CD011281-cr-0002"><i class="icon corresponding-author fa fa-envelope"></i>Carlos A Andrade‐Castellanos</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#CD011281-cr-0003">Luis Enrique Colunga‐Lozano</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#CD011281-cr-0004">Netzahualpilli Delgado‐Figueroa</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information#CD011281-cr-0005">Daniel A Gonzalez‐Padilla</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information/en#CD011281-sec-0123">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 January 2016 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011281.pub2">https://doi.org/10.1002/14651858.CD011281.pub2</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011281-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-abs-0002">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011281-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/th#CD011281-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011281-abs-0012">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011281-abs-0001" lang="en"> <section id="CD011281-sec-0001"> <h3 class="title" id="CD011281-sec-0001">Background</h3> <p>Diabetic ketoacidosis (DKA) is an acute, life‐threatening complication of uncontrolled diabetes that mainly occurs in individuals with autoimmune type 1 diabetes, but it is not uncommon in some people with type 2 diabetes. The treatment of DKA is traditionally accomplished by the administration of intravenous infusion of regular insulin that is initiated in the emergency department and continued in an intensive care unit or a high‐dependency unit environment. It is unclear whether people with DKA should be treated with other treatment modalities such as subcutaneous rapid‐acting insulin analogues. </p> </section> <section id="CD011281-sec-0002"> <h3 class="title" id="CD011281-sec-0002">Objectives</h3> <p>To assess the effects of subcutaneous rapid‐acting insulin analogues for the treatment of diabetic ketoacidosis. </p> </section> <section id="CD011281-sec-0003"> <h3 class="title" id="CD011281-sec-0003">Search methods</h3> <p>We identified eligible trials by searching MEDLINE, PubMed, EMBASE, LILACS, CINAHL, and the Cochrane Library. We searched the trials registers WHO ICTRP Search Portal and ClinicalTrials.gov. The date of last search for all databases was 27 October 2015. We also examined reference lists of included randomised controlled trials (RCTs) and systematic reviews, and contacted trial authors. </p> </section> <section id="CD011281-sec-0004"> <h3 class="title" id="CD011281-sec-0004">Selection criteria</h3> <p>We included trials if they were RCTs comparing subcutaneous rapid‐acting insulin analogues versus standard intravenous infusion in participants with DKA of any age or sex with type 1 or type 2 diabetes, and in pregnant women. </p> </section> <section id="CD011281-sec-0005"> <h3 class="title" id="CD011281-sec-0005">Data collection and analysis</h3> <p>Two review authors independently extracted data, assessed studies for risk of bias, and evaluated overall study quality utilising the GRADE instrument. We assessed the statistical heterogeneity of included studies by visually inspecting forest plots and quantifying the diversity using the I² statistic. We synthesised data using random‐effects model meta‐analysis or descriptive analysis, as appropriate. </p> </section> <section id="CD011281-sec-0006"> <h3 class="title" id="CD011281-sec-0006">Main results</h3> <p>Five trials randomised 201 participants (110 participants to subcutaneous rapid‐acting insulin analogues and 91 to intravenous regular insulin). The criteria for DKA were consistent with the American Diabetes Association criteria for mild or moderate DKA. The underlying cause of DKA was mostly poor compliance with diabetes therapy. Most trials did not report on type of diabetes. Younger diabetic participants and children were underrepresented in our included trials (one trial only). Four trials evaluated the effects of the rapid‐acting insulin analogue lispro, and one the effects of the rapid‐acting insulin analogue aspart. The mean follow‐up period as measured by mean hospital stay ranged between two and seven days. Overall, risk of bias of the evaluated trials was unclear in many domains and high for performance bias for the outcome measure time to resolution of DKA. </p> <p>No deaths were reported in the included trials (186 participants; 3 trials; moderate‐ (insulin lispro) to low‐quality evidence (insulin aspart)). There was very low‐quality evidence to evaluate the effects of subcutaneous insulin lispro versus intravenous regular insulin on the time to resolution of DKA: mean difference (MD) 0.2 h (95% CI ‐1.7 to 2.1); P = 0.81; 90 participants; 2 trials. In one trial involving children with DKA, the time to reach a glucose level of 250 mg/dL was similar between insulin lispro and intravenous regular insulin. There was very low‐quality evidence to evaluate the effects of subcutaneous insulin aspart versus intravenous regular insulin on the time to resolution of DKA: MD ‐1 h (95% CI ‐3.2 to 1.2); P = 0.36; 30 participants; 1 trial. There was low‐quality evidence to evaluate the effects of subcutaneous rapid‐acting insulin analogues versus intravenous regular insulin on hypoglycaemic episodes: 6 of 80 insulin lispro‐treated participants compared with 9 of 76 regular insulin‐treated participants reported hypoglycaemic events; risk ratio (RR) 0.59 (95% CI 0.23 to 1.52); P = 0.28; 156 participants; 4 trials. For insulin aspart compared with regular insulin, RR for hypoglycaemic episodes was 1.00 (95% CI 0.07 to 14.55); P = 1.0; 30 participants; 1 trial; low‐quality evidence. Socioeconomic effects as measured by length of mean hospital stay for insulin lispro compared with regular insulin showed a MD of ‐0.4 days (95% CI ‐1 to 0.2); P = 0.22; 90 participants; 2 trials; low‐quality evidence and for insulin aspart compared with regular insulin 1.1 days (95% CI ‐3.3 to 1.1); P = 0.32; low‐quality evidence. Data on morbidity were limited, but no specific events were reported for the comparison of insulin lispro with regular insulin. No trial reported on adverse events other than hypoglycaemic episodes, and no trial investigated patient satisfaction. </p> </section> <section id="CD011281-sec-0007"> <h3 class="title" id="CD011281-sec-0007">Authors' conclusions</h3> <p>Our review, which provided mainly data on adults, suggests on the basis of mostly low‐ to very low‐quality evidence that there are neither advantages nor disadvantages when comparing the effects of subcutaneous rapid‐acting insulin analogues versus intravenous regular insulin for treating mild or moderate DKA. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011281-abs-0003" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-abs-0003">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011281-abs-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-abs-0007">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011281-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011281-abs-0006">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011281-abs-0005">Русский</a> </li> <li class="section-language"> <a class="" href="full/th#CD011281-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011281-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011281-abs-0003" lang="en"> <h3>Subcutaneous rapid‐acting insulin analogues for diabetic ketoacidosis</h3> <p><b>Review question</b> </p> <p>What are the effects of subcutaneous rapid‐acting insulin analogues compared with standard intravenous infusion of regular insulin for the treatment of diabetic ketoacidosis? </p> <p><b>Background</b> </p> <p>Rapid‐acting insulin analogues (artificial insulin such as insulin lispro, insulin aspart, or insulin glulisine) act more quickly than regular human insulin. In people with a specific type of life‐threatening diabetic coma due to uncontrolled diabetes, called diabetic ketoacidosis, prompt administration of intravenous regular insulin is standard therapy. The rapid‐acting insulin analogues, if injected subcutaneously, act faster than subcutaneously administered regular insulin. The need for a continuous intravenous infusion, an intervention that usually requires admission to an intensive care unit, can thereby be avoided. This means that subcutaneously given insulin analogues for diabetic ketoacidosis might be applied in the emergency department and a general medicine ward. </p> <p><b>Study characteristics</b> </p> <p>We found five randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) with a total of 201 participants. Most trials did not report on type of diabetes. Younger diabetic participants and children were underrepresented in our included trials (one trial only). Participants in four trials received treatment with insulin lispro, and one trial with 45 participants investigated insulin aspart. The average follow‐up as measured by mean hospital stay ranged between two and seven days. The study authors termed the diabetic ketoacidosis being treated with insulin analogues or regular insulin as mild or moderate. This evidence is up to date as of October 2015. </p> <p><b>Key results</b> </p> <p>Our results are most relevant for adults with mild or moderate diabetic ketoacidosis due to undertreatment of diabetes. No deaths occurred. Time to resolution of diabetic ketoacidosis from the start of therapy did not differ substantially between the two insulin treatment schemes (approximately 11 hours). Hypoglycaemic (low blood sugar) episodes were comparable: 118 per 1000 participants for intravenous insulin compared with 70 per 1000 participants for subcutaneous insulin lispro (no statistically significant difference). The mean length of hospital stay also showed no marked differences. No trial reported on side effects other than hypoglycaemic episodes or investigated patient satisfaction. No serious events associated with diabetic ketoacidosis were seen during insulin lispro treatment. </p> <p><b>Quality of the evidence</b> </p> <p>Our results were limited by mostly low‐ to very low‐quality evidence, mainly because the number of included trials and participants was low. Further research is very likely to have an important impact on our findings. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011281-sec-0103" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-sec-0103">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-sec-0157">Español</a> </li> </nav> </div> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011281-sec-0103"></div> <h3 class="title" id="CD011281-sec-0104">Implications for practice</h3> <section id="CD011281-sec-0104"> <p>Our analyses suggest that, on the basis of mostly low‐ to very low‐quality evidence, there are neither advantages nor disadvantages when comparing the effects of subcutaneous rapid‐acting insulin analogues (insulin lispro, insulin aspart) versus intravenous regular insulin for treating DKA. These results are most relevant to adults with a mild or moderate DKA episode due to poor compliance with diabetes therapy. </p> </section> <h3 class="title" id="CD011281-sec-0105">Implications for research</h3> <section id="CD011281-sec-0105"> <p>Due to the paucity of high‐quality evidence from RCTs comparing insulin interventions for DKA, future trials have the potential to change our way of treating this debilitating and expensive condition. </p> <p>Future RCTs should adequately report on the method of randomisation and treatment allocation concealment. Blinding of study participants, study personnel, and outcome assessors could be done by using double‐dummy designs. Follow‐up of participants should be longer, and trial authors should adhere to the intention‐to‐treat principle. In addition, outcome measures should include patient satisfaction, morbidity, and socioeconomic effects. Finally, multicentre trials are desirable to ensure external validity. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011281-sec-0029" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011281-sec-0029"></div> <div class="table" id="CD011281-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Subcutaneous insulin lispro versus intravenous regular insulin for diabetic ketoacidosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Subcutaneous insulin lispro versus intravenous regular insulin for diabetic ketoacidosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient:</b> participants with diabetic ketoacidosis<br/> <b>Settings:</b> emergency department and critical care unit<br/> <b>Intervention:</b> subcutaneous insulin lispro versus intravenous regular insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intravenous regular insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Subcutaneous insulin lispro</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality (N)</b> </p> <p>Mean hospital stay: 2‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No deaths reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hypoglycaemic episodes (N)</b> </p> <p>Mean hospital stay: 2‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>118 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> <br/> (27 to 180) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.59</b> <br/> (0.23 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparable risk ratios for adults (4 trials) and children (1 trial)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Morbidity (N)</b> </p> <p>Mean hospital stay: 2‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No cases of cerebral oedema, venous thrombosis, adult respiratory distress syndrome, hyperchloraemic acidosis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events other than hypoglycaemic episodes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to resolution of diabetic ketoacidosis (h)</b> </p> <p>Mean hospital stay: 2‐4 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis across the intravenous regular insulin groups was 11 h </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis in the subcutaneous insulin lispro groups was <b>0.2 h higher</b> (1.7 h lower to 2.1 h higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Metabolic acidosis and ketosis took longer to resolve in the subcutaneous insulin lispro group in 1 trial (60 children); no exact data published </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Socioeconomic effects: length of hospital stay (days)</b> </p> <p>Mean hospital stay: 4‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intravenous regular insulin groups ranged between 4 and 6.6 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the subcutaneous insulin lispro groups was <b>0.4 days shorter</b> (1 day shorter to 0.2 days longer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>d</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US setting: treatment of diabetic ketoacidosis in a non–intensive care setting (step‐down unit or general medicine ward) was associated with a 39% lower hospitalisation charge than was treatment with intravenous regular insulin in the intensive care unit (USD 8801 (SD USD 5549) vs USD 14,429 (SD USD 5243); the average hospitalisation charges per day were USD 3981 (SD USD 1067) for participants treated in an intensive care unit compared with USD 2682 (SD USD 636) for those treated in a non–intensive care setting </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>h:</b> hours; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*Assumed risk was derived from the event rates in the comparator groups.<br/> <sup>a</sup>Downgraded by one level because of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>).<br/> <sup>b</sup>Downgraded by two levels because of risk of performance bias and serious imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>).<br/> <sup>c</sup>Downgraded by three levels because of risk of performance bias, serious risk of inconsistency, and serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>).<br/> <sup>d</sup>Downgraded by two levels because of serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD011281-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subcutaneous insulin aspart versus intravenous regular insulin for diabetic ketoacidosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Subcutaneous insulin aspart versus intravenous regular insulin for diabetic ketoacidosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient:</b> participants with diabetic ketoacidosis<br/> <b>Settings:</b> general medicine ward and intensive care unit<br/> <b>Intervention:</b> subcutaneous insulin aspart versus intravenous regular insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intravenous regular insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Subcutaneous insulin aspart</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality (N)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No deaths reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hypoglycaemic episodes (N)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> <br/> (5 to 970) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> <br/> (0.07 to 14.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Morbidity</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events other than hypoglycaemic episodes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to resolution of diabetic ketoacidosis (h)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis across the intravenous regular insulin groups was 11 h </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis in the subcutaneous insulin aspart group was <b>1 h lower</b> (3.2 h lower to 1.2 h higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Socioeconomic effects: length of hospital stay (days)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intravenous regular insulin group was 4.5 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the subcutaneous insulin aspart group was <b>1.1 days shorter</b> (3.3 days shorter to 1.1 days longer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>d</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>h:</b> hours; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*Assumed risk was derived from the event rates in the comparator groups<br/> <sup>a</sup>Downgraded by two levels because of serious imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>)<br/> <sup>b</sup>Downgraded by two levels because of risk of performance bias and imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>)<br/> <sup>c</sup>Downgraded by three levels because of risk of performance bias and serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>)<br/> <sup>d</sup>Downgraded by two levels because of serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>) </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011281-sec-0030" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-sec-0030">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-sec-0132">Español</a> </li> </nav> </div> </div> <section class="background" lang="en"> <div class="section-header" id="CD011281-sec-0030"></div> <section id="CD011281-sec-0031"> <h3 class="title" id="CD011281-sec-0031">Description of the condition</h3> <p>Diabetes mellitus is a metabolic disorder resulting from a defect in insulin secretion, insulin action, or both. A consequence of this is chronic hyperglycaemia (that is elevated levels of plasma glucose) with disturbances of carbohydrate, fat, and protein metabolism. Long‐term complications of diabetes mellitus include retinopathy, nephropathy, and neuropathy. The risk of cardiovascular disease is increased. Individuals with diabetes may be admitted to the hospital as a result of diabetic emergencies such as diabetic ketoacidosis (DKA) or hyperosmolar hyperglycaemic state (HHS). DKA is an acute, major, life‐threatening complication of diabetes that occurs mainly in individuals with autoimmune type 1 diabetes, but it is not uncommon in some people with type 2 diabetes (<a href="./references#CD011281-bbs2-0047" title="KitabchiAE , UmpierrezGE , MilesJM , FisherJN . Hyperglycemic crises in adult patients with diabetes. Diabetes Care2009;32(7):1335‐43. ">Kitabchi 2009</a>). DKA and HHS represent the most extreme consequences of uncontrolled diabetes mellitus. </p> <p>In the USA, the incidence rate for DKA ranges from 4.6 to 8 episodes per 1000 people with diabetes of all ages, and 13.4 episodes per 1000 people with diabetes who are younger than 30 years old (<a href="./references#CD011281-bbs2-0032" title="FaichGA , FishbeinHA , EllisSE . The epidemiology of diabetic acidosis: a population‐based study. American Journal of Epidemiology1983;117(5):551‐8. ">Faich 1983</a>; <a href="./references#CD011281-bbs2-0043" title="JohnsonDD , PalumboPJ , ChuCP . Diabetic ketoacidosis in a community‐based population. Mayo Clinic Proceedings1980;55(2):83‐8. ">Johnson 1980</a>). The incidence rate in the USA is comparable to the rates in Europe, with estimates of 13.6 per 1000 people with type 1 diabetes in the UK (<a href="./references#CD011281-bbs2-0031" title="DaveJ , ChatterjeeS , DaviesM , HigginsK , MorjariaH , McNallyP , et al. Evaluation of admissions and management of diabetic ketoacidosis in a large teaching hospital. Practical Diabetes International2004;21(4):149‐53. ">Dave 2004</a>). The mortality rate of DKA currently ranges from 0% to 19%, a rate that has shown a little decline in recent years (<a href="./references#CD011281-bbs2-0029" title="BasuA , CloseCF , JenkinsD , KrentzAJ , NattrassM , WrightAD . Persisting mortality in diabetic ketoacidosis. Diabetic Medicine1993;10:282‐4. ">Basu 1993</a>; <a href="./references#CD011281-bbs2-0064" title="WarnerDP , MckinneyPA , LawGR , BodanskyHJ . Mortality and diabetes from a population based study in Yorkshire. Archives of Disease in Childhood1998;78:435‐8. ">Warner 1998</a>). Mortality rates increase substantially with age and in the presence of concomitant life‐threatening illnesses such as co‐existent kidney disease and infections (<a href="./references#CD011281-bbs2-0051" title="MaloneML , GennisV , GoodwinJS . Characteristics of diabetic ketoacidosis in older versus younger adults. Journal of the American Geriatrics Society1992;40(11):1100‐4. ">Malone 1992</a>). Hyperglycaemic crises are also economically burdensome, as DKA is responsible for more than 500,000 hospital days per year at an estimated annual direct medical expense and indirect cost of USD 2.4 billion (<a href="./references#CD011281-bbs2-0044" title="KimS . Burden of hospitalizations primarily due to uncontrolled diabetes: implications of inadequate primary health care in the United States. Diabetes Care2007;30(5):1281‐2. ">Kim 2007</a>). </p> <p>The basic mechanism for the development of DKA is a reduction in the effective insulin concentration and increased counter‐regulatory (catabolic or stress) hormones like glucagon, catecholamine, cortisol, and growth hormone. The hyperglycaemia of DKA results from increased hepatic glucose production (gluconeogenesis and glycogenolysis) and impaired peripheral glucose utilisation. Ketone bodies result from a marked increase in the free fatty acid release from adipocytes, with a resulting shift toward ketone body synthesis in the liver. This hormonal imbalance leads to the biochemical triad of DKA: hyperglycaemia, ketonaemia, and acidaemia (<a href="./references#CD011281-bbs2-0046" title="KitabchiAE , UmpierrezGE , MurphyMB , BarrettEJ , KreisbergRA , MaloneJI , et al. Management of hyperglycemic crises in patients with diabetes. Diabetes Care2001;24:131‐53. ">Kitabchi 2001</a>). People with DKA are invariably volume depleted because insulin deficiency in DKA leads to hyperglycaemic osmotic diuresis and progressive volume depletion. Glycosuria is also accompanied by large urinary losses of potassium and phosphorus. The above processes can have several consequences, including tissue hypoxia, hyperviscosity, arrhythmia, and decreased blood flow to target organs like the brain. </p> <p>Successful treatment of DKA requires correction of hyperglycaemia, skillful fluid and electrolyte adjustments, identification of comorbid precipitating events, and above all frequent and close monitoring of the patient (<a href="./references#CD011281-bbs2-0047" title="KitabchiAE , UmpierrezGE , MilesJM , FisherJN . Hyperglycemic crises in adult patients with diabetes. Diabetes Care2009;32(7):1335‐43. ">Kitabchi 2009</a>). The treatment of diabetic ketoacidosis is traditionally accomplished by the administration of intravenous infusion of regular insulin, which is initiated in the emergency department and continued in an intensive care unit (ICU) or a high‐dependency unit environment, as endorsed by the American Diabetes Association and the Joint British Diabetes Societies guideline for the management of DKA (<a href="./references#CD011281-bbs2-0047" title="KitabchiAE , UmpierrezGE , MilesJM , FisherJN . Hyperglycemic crises in adult patients with diabetes. Diabetes Care2009;32(7):1335‐43. ">Kitabchi 2009</a>; <a href="./references#CD011281-bbs2-0061" title="SavageMW , DhatariyaKK , KilvertA , RaymanG , ReesJA , CourtneyCH , et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabetic Medicine2011;28(5):508‐15. ">Savage 2011</a>). </p> </section> <section id="CD011281-sec-0032"> <h3 class="title" id="CD011281-sec-0032">Description of the intervention</h3> <p>The first priority in the treatment of DKA is to restore intravascular volume to normalise tissue perfusion and aid in the delivery of insulin to target organs. Insulin administration is essential in the treatment and is initiated immediately, unless there is evidence of severe hypovolaemia or hypokalaemia. Insulin therapy lowers the serum glucose concentration primarily by decreasing hepatic glucose production rather than enhancing peripheral utilisation (<a href="./references#CD011281-bbs2-0050" title="LuziL , BarrettEJ , GroopLC , FerranniniE , DeFronzoRA . Metabolic effects of low‐dose insulin therapy on glucose metabolism in diabetic ketoacidosis. Diabetes1988;37(11):1470‐7. ">Luzi 1988</a>), diminishes ketone production (by reducing both lipolysis and glucagon secretion), and may augment ketone clearance. Insulin administration seeks to restore normal glucose uptake by cells; however, excessive insulin administration must be avoided to prevent hypoglycaemia and hypokalaemia. </p> <p>The route of administration of insulin in the management of DKA has been debated since the early 1970s. <a href="./references#CD011281-bbs2-0027" title='AlbertiKG , HockadayTD , TurnerRC . Small doses of intramuscular insulin in the treatment of diabetic "coma". The Lancet1973;2(7828):515‐22. '>Alberti 1973</a> reported the results of low‐dose intramuscular insulin in the management of people with DKA. They found that an initial average bolus dose of 16 units followed by 5 to 10 units of intramuscular regular insulin per hour was effective in correcting hyperglycaemia and acidaemia. Later in the 1970s, Fisher and colleagues reported a greater decline in blood glucose and ketone body levels in the first two hours of therapy with intravenous insulin as compared to intramuscular or subcutaneous insulin (<a href="./references#CD011281-bbs2-0009" title="FisherJN , ShahshahaniMN , KitabchiAE . Diabetic ketoacidosis: low‐dose insulin therapy by various routes. The New England Journal of Medicine1977;297(5):238‐41. ">Fisher 1977</a>). Furthermore, the dehydration and shock state of people with DKA leads to erratic and unpredictable absorption of intramuscular and subcutaneous insulin (<a href="./references#CD011281-bbs2-0009" title="FisherJN , ShahshahaniMN , KitabchiAE . Diabetic ketoacidosis: low‐dose insulin therapy by various routes. The New England Journal of Medicine1977;297(5):238‐41. ">Fisher 1977</a>). Based on this finding, it is now generally accepted that continuous intravenous infusion is the most effective route of insulin administration (<a href="./references#CD011281-bbs2-0061" title="SavageMW , DhatariyaKK , KilvertA , RaymanG , ReesJA , CourtneyCH , et al. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis. Diabetic Medicine2011;28(5):508‐15. ">Savage 2011</a>). </p> <p>Randomised controlled trials in people with DKA have shown insulin therapy to be effective regardless of the administration route. Treatment with subcutaneous rapid‐acting insulin analogues administered every one to two hours has been shown to be an effective alternative to the use of intravenous regular insulin in the treatment of uncomplicated DKA (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). In one of these trials, the authors found that the effects in people treated with subcutaneous insulin lispro were comparable with those treated with intravenous regular insulin. The authors observed similar rates of death, length of hospital stay, and amount of insulin used until resolution of DKA between treatment groups. Treatment of DKA in the ICU was associated with 39% higher hospitalisation charges than was treatment with subcutaneous lispro in a non‐intensive care setting (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). </p> <section id="CD011281-sec-0033"> <h4 class="title">Adverse effects of the intervention</h4> <p>Hypoglycaemia is an inherent adverse effect of insulin treatment. Additionally, insulin therapy is associated with injection site reactions, generalised sensitivity reactions, and electrolyte imbalances such as hypokalaemia. Concern has been raised regarding potential mitogenic effects of insulin analogues, but evidence is controversial (<a href="./references#CD011281-bbs2-0033" title="HemkensLG , GrouvenU , BenderR , GünsterC , GutschmidtS , SelkeGW , et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia2009;52(9):1732‐44. ">Hemkens 2009</a>; <a href="./references#CD011281-bbs2-0048" title="KurtzhalsP , SchäfferL , SørensenA , KristensenC , JonassenI , SchmidC , et al. Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use. Diabetes2000;49(6):999‐1005. ">Kurtzhals 2000</a>). Insulin lispro and insulin aspart, like human insulin, are rated category B for pregnancy use, which means that well‐controlled trials in pregnant women are lacking, while insulin glulisine is category C, because only animal reproduction studies have been performed with it (<a href="./references#CD011281-bbs2-0040" title="HomePD . The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences. Diabetes, Obesity &amp; Metabolism2012;14(9):780‐8. ">Home 2012</a>). </p> </section> </section> <section id="CD011281-sec-0034"> <h3 class="title" id="CD011281-sec-0034">How the intervention might work</h3> <p>In the last decade, considerable attention has been devoted to the development of insulin analogues with pharmacokinetic profiles that differ from existing insulin preparations. Compared to regular human insulin, proline at position 28 and lysine at position 29 of the B‐region were interchanged in the short‐acting insulin analogue lispro. In the short‐acting insulin analogue aspart, proline at position 28 of the B‐region was replaced by aspartic acid, and in the short‐acting insulin analogue glulisine, the amino acid asparagine was replaced by lysine at position three and lysine with glutamic acid at position 29 of the B‐chain (<a href="./references#CD011281-bbs2-0062" title="SiebenhoferA , PlankJ , BergholdA , JeitlerK , HorvathK , NarathM , et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003287] ">Siebenhofer 2006</a>). Insulin lispro, insulin aspart, and insulin glulisine have very similar pharmacokinetic profiles. These analogues are present either in a monomeric form or a very weakly bound hexameric form. Following subcutaneous injection, they are rapidly absorbed in less than 30 minutes, with a short peak time of insulin concentration of 1 hour and a shorter duration of action of 3 to 4 hours when compared with regular human insulin (<a href="./references#CD011281-bbs2-0060" title="RoachP . New insulin analogues and routes of delivery: pharmacodynamic and clinical considerations. Clinical Pharmacokinetics2008;47(9):595‐610. ">Roach 2008</a>). </p> <p>Data on rapid‐acting insulin analogues in clinical trials (not in DKA) suggest lower postprandial glucose variations when compared with meal‐time human insulin in adults and children, and in type 1 and type 2 diabetes (<a href="./references#CD011281-bbs2-0039" title="HomePD , LindholmA , RiisA , European Insulin Aspart Study Group. Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial. Diabetic Medicine2000;17(11):762‐70. ">Home 2000</a>; <a href="./references#CD011281-bbs2-0052" title="MathiesenER , KinsleyB , AmielSA , HellerS , McCanceD , DuranS , et al. Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women. Diabetes Care2007;30(4):771‐6. ">Mathiesen 2007</a>; <a href="./references#CD011281-bbs2-0057" title="RaymanG , ProfozicV , MiddleM . Insulin glulisine imparts effective glycaemic control in patients with Type 2 diabetes. Diabetes Research and Clinical Practice2007;76(2):304‐12. ">Rayman 2007</a>). The decreased incidence of major hypoglycaemia requiring third‐party assistance, in particular major nocturnal hypoglycaemia, is the expected consequence of the shorter subcutaneous availability time of rapid‐acting insulin analogues. In people with type 1 diabetes, the median incidence of severe hypoglycaemia for rapid‐acting analogues is 21.8 episodes per 100 person‐years compared with 46.1 episodes for human insulin (<a href="./references#CD011281-bbs2-0062" title="SiebenhoferA , PlankJ , BergholdA , JeitlerK , HorvathK , NarathM , et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003287] ">Siebenhofer 2006</a>). In people with type 2 diabetes, the median incidence is 0.3 episodes per 100 person‐years for analogues compared with a mean of 1.4 episodes per 100 person‐years for human insulin (<a href="./references#CD011281-bbs2-0062" title="SiebenhoferA , PlankJ , BergholdA , JeitlerK , HorvathK , NarathM , et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database of Systematic Reviews2006, Issue 2. [DOI: 10.1002/14651858.CD003287] ">Siebenhofer 2006</a>). </p> <p>The pharmacokinetic profile of rapid‐acting analogues following subcutaneous injection suggests that they might be a feasible alternative in the case of DKA, that is faster rise in plasma concentration, higher peak concentration, and shorter subcutaneous residence time than unmodified human insulin (<a href="./references#CD011281-bbs2-0041" title="HoweyDC , BowsherRR , BrunelleRL , RoweHM , SantaPF , Downing‐SheltonJ , et al. [Lys(B28), Pro(B29)]‐human insulin: effect of injection time on postprandial glycemia. Clinical Pharmacology and Therapeutics1995;58(4):459‐69. ">Howey 1995</a>). </p> </section> <section id="CD011281-sec-0035"> <h3 class="title" id="CD011281-sec-0035">Why it is important to do this review</h3> <p>As an alternative to an intravenous infusion of regular insulin, people with mild to moderate DKA can be treated with subcutaneous rapid‐acting insulin analogues, offering an opportunity to avoid costly admissions (<a href="./references#CD011281-bbs2-0047" title="KitabchiAE , UmpierrezGE , MilesJM , FisherJN . Hyperglycemic crises in adult patients with diabetes. Diabetes Care2009;32(7):1335‐43. ">Kitabchi 2009</a>; <a href="./references#CD011281-bbs2-0056" title="NyenweEA , KitabchiAE . Evidence‐based management of hyperglycemic emergencies in diabetes mellitus. Diabetes Research and Clinical Practice2011;94(3):340‐51. ">Nyenwe 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Delivery of care without constant patient monitoring (for example outside ICU settings) will undoubtedly reduce cost. Also, stable patients could be treated in a step‐down unit close to their relatives. </p> <p>Two systematic reviews comparing rapid‐acting insulin analogues with intravenous infusion of regular insulin in the treatment of mild to moderate DKA have been published (<a href="./references#CD011281-bbs2-0053" title="MazerM , ChenE . Is subcutaneous administration of rapid‐acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?. Annals of Emergency Medicine2009;53(2):259‐63. ">Mazer 2009</a>; <a href="./references#CD011281-bbs2-0019" title="VincentM , NobécourtE . Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes &amp; Metabolism2013;39(4):299‐305. ">Vincent 2013</a>). Both reviews provide an overview of the studies located, however there are some limitations. Firstly, the comprehensiveness of systematic literature searches was suboptimal. The literature search in Vincent 2013 was restricted exclusively to the PubMed database. Secondly, assessments of risk of bias of studies were not specified (<a href="./references#CD011281-bbs2-0053" title="MazerM , ChenE . Is subcutaneous administration of rapid‐acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?. Annals of Emergency Medicine2009;53(2):259‐63. ">Mazer 2009</a>; <a href="./references#CD011281-bbs2-0019" title="VincentM , NobécourtE . Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes &amp; Metabolism2013;39(4):299‐305. ">Vincent 2013</a>). </p> <p>Given the limitations of previous systematic reviews, we plan to use specific methodology and criteria outlined by Cochrane in our aim to present a comprehensive systematic review to assess the efficacy and safety of subcutaneous rapid‐acting insulin analogues in the treatment of DKA in adults and children. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011281-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-sec-0036">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-sec-0138">Español</a> </li> </nav> </div> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011281-sec-0036"></div> <p>To assess the effects of subcutaneous rapid‐acting insulin analogues for the treatment of diabetic ketoacidosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011281-sec-0037" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-sec-0037">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-sec-0139">Español</a> </li> </nav> </div> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011281-sec-0037"></div> <section id="CD011281-sec-0038"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011281-sec-0039"> <h4 class="title">Types of studies</h4> <p>We included randomised controlled trials (RCTs).</p> </section> <section id="CD011281-sec-0040"> <h4 class="title">Types of participants</h4> <p>We included trials evaluating participants with diabetic ketoacidosis (DKA) of any age or sex with type 1 or type 2 diabetes, and pregnant women (including gestational diabetes). </p> <p><b>Diagnostic criteria for diabetes mellitus</b> </p> <p>In order to be consistent with changes in classification and diagnostic criteria of diabetes mellitus over the years, we used the diagnostic criteria valid at the time of the trial commencing (for example <a href="./references#CD011281-bbs2-0024" title="The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care1999;22(Suppl 1):S5‐19. ">ADA 1999</a>; <a href="./references#CD011281-bbs2-0026" title="American Diabetes Association. Standards of medical care in diabetes ‐ 2008. Diabetes Care2008;31(Suppl 1):S12‐54. [PUBMED: 18165335] ">ADA 2008</a>; <a href="./references#CD011281-bbs2-0065" title="AlbertiKM , ZimmetPZ . Definition, diagnosis and classification of diabetes mellitus and its complications. Part I: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabetic Medicine1998;15:539‐53. ">WHO 1998</a>). We used the study authors' definition of diabetes mellitus if necessary. We planned to subject diagnostic criteria to a sensitivity analysis. </p> <p><b>Diagnostic criteria for diabetic ketoacidosis</b> </p> <p>We used the American Diabetes Association criteria for DKA (<a href="./references#CD011281-bbs2-0025" title="American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care2004;27(Suppl 1):S94‐102. ">ADA 2004</a>), which are as follows. </p> <p> <ul id="CD011281-list-0001"> <li> <p>Mild DKA: plasma glucose &gt; 250 mg/dL, arterial pH 7.25 to 7.30, serum bicarbonate 15 to 18 mEq/L, urine and serum ketones positive, anion gap &gt; 10, alteration in sensoria or mental obtundation as alert. </p> </li> <li> <p>Moderate DKA: plasma glucose &gt; 250 mg/dL, arterial pH 7.00 to 7.24, serum bicarbonate 10 to &lt; 15 mEq/L, urine and serum ketones positive, anion gap &gt; 12, alteration in sensoria or mental obtundation as alert/drowsy. </p> </li> <li> <p>Severe DKA: plasma glucose &gt; 250 mg/dL, arterial pH &lt; 7.00, serum bicarbonate &lt; 10 mEq/L, urine and serum ketones positive, anion gap &gt; 12, alteration in sensoria or mental obtundation as stupor/coma. </p> </li> </ul> </p> </section> <section id="CD011281-sec-0041"> <h4 class="title">Types of interventions</h4> <p>We planned to investigate the effects of subcutaneous rapid‐acting insulin analogues versus standard intravenous infusion of regular insulin. We expected insulin regimens (use of intravenous bolus, dose, and frequency) to vary depending on the study, therefore we accepted all insulin regimens. </p> <section id="CD011281-sec-0042"> <h5 class="title">Intervention</h5> <p> <ul id="CD011281-list-0002"> <li> <p>Subcutaneous rapid‐acting insulin analogues (insulin lispro, insulin aspart, or insulin glulisine). </p> </li> </ul> </p> </section> <section id="CD011281-sec-0043"> <h5 class="title">Comparator</h5> <p> <ul id="CD011281-list-0003"> <li> <p>Intravenous infusion of regular insulin.</p> </li> </ul> </p> <p>Concomitant interventions had to be the same in the intervention and comparator groups to establish fair comparisons. </p> </section> </section> <section id="CD011281-sec-0044"> <h4 class="title">Types of outcome measures</h4> <section id="CD011281-sec-0045"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011281-list-0004"> <li> <p>Time to resolution of DKA.</p> </li> <li> <p>All‐cause mortality.</p> </li> <li> <p>Hypoglycaemic episodes.</p> </li> </ul> </p> </section> <section id="CD011281-sec-0046"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011281-list-0005"> <li> <p>Morbidity.</p> </li> <li> <p>Adverse events other than hypoglycaemia.</p> </li> <li> <p>Patient satisfaction.</p> </li> <li> <p>Glycosylated haemoglobin A1c (HbA1c).</p> </li> <li> <p>Socioeconomic effects.</p> </li> </ul> </p> <section id="CD011281-sec-0047"> <h6 class="title">Method and timing of outcome measurement</h6> <p> <ul id="CD011281-list-0006"> <li> <p>Time to resolution of DKA: defined as time to reach blood glucose levels &lt; 200 mg/dL and two of the following criteria: a serum bicarbonate level ≥ 15 mEq/L, a venous pH &gt; 7.3, and a calculated anion gap ≤ 12 mEq/L (<a href="./references#CD011281-bbs2-0047" title="KitabchiAE , UmpierrezGE , MilesJM , FisherJN . Hyperglycemic crises in adult patients with diabetes. Diabetes Care2009;32(7):1335‐43. ">Kitabchi 2009</a>). </p> </li> <li> <p>All‐cause mortality: defined as the total number of deaths from any cause and measured as in‐hospital mortality and 30‐day all‐cause mortality. </p> </li> <li> <p>Hypoglycaemic episodes: defined as a symptomatic or asymptomatic event with plasma glucose ≤ 70 mg/dL (3.9 mmol/L) or according to authors' definition. </p> </li> <li> <p>Morbidity: such as cerebral oedema defined by diagnostic criteria, including abnormal motor or verbal responses to pain, decorticate posture, and abnormal neurogenic respiratory patterns (major, but not diagnostic criteria include altered mentation, sustained heart rate decelerations, and age‐inappropriate incontinence; minor criteria include vomiting, headache, lethargy, diastolic blood pressure &gt; 90 mm Hg, and age &lt; 5 years (<a href="./references#CD011281-bbs2-0055" title="MuirAB , QuislingRG , YangMC , RosenbloomAL . Cerebral edema in childhood diabetic ketoacidosis: natural history, radiographic findings, and early identification. Diabetes Care2004;27(7):1541‐6. ">Muir 2004</a>)). </p> </li> <li> <p>Adverse events other than hypoglycaemia: such as hypokalaemia defined as a serum potassium concentration &lt; 3.5 mEq/L, and injection site reactions. </p> </li> <li> <p>Patient satisfaction: evaluated with a validated instrument such as the Insulin Treatment Satisfaction Questionnaire (<a href="./references#CD011281-bbs2-0028" title="AndersonRT , SkovlundSE , MarreroD , LevineDW , MeadowsK , BrodM , et al. Development and validation of the insulin treatment satisfaction questionnaire. Clinical Therapeutics2004;26(4):565‐78. ">Anderson 2004</a>). </p> </li> <li> <p>HbA1c: measured at hospital admission (baseline) and at three months postdischarge.</p> </li> <li> <p>Socioeconomic effects: such as length of hospital stay, calculated by subtracting day of admission from day of discharge, and costs, measured as data on hospital charges. </p> </li> </ul> </p> </section> <section id="CD011281-sec-0048"> <h6 class="title">'Summary of findings' table</h6> <p>We present a 'Summary of findings' table reporting the following outcomes listed according to priority. </p> <p> <ol id="CD011281-list-0007"> <li> <p>All‐cause mortality.</p> </li> <li> <p>Hypoglycaemic episodes.</p> </li> <li> <p>Morbidity.</p> </li> <li> <p>Adverse events other than hypoglycaemic episodes.</p> </li> <li> <p>Time to resolution of DKA.</p> </li> <li> <p>Patient satisfaction.</p> </li> <li> <p>Socioeconomic effects.</p> </li> </ol> </p> </section> </section> </section> </section> <section id="CD011281-sec-0049"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011281-sec-0050"> <h4 class="title">Electronic searches</h4> <p>We searched the following sources from inception of each database to the specified date and placed no restrictions on the language of publication. </p> <p> <ul id="CD011281-list-0008"> <li> <p>Cochrane Library (27 October 2015)</p> <ul id="CD011281-list-0009"> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL) (Issue 9, September 2015)</p> </li> <li> <p>Database of Abstracts of Reviews of Effects (DARE) (Issue 2, April 2015)</p> </li> <li> <p>Health Technology Assessment (HTA) Database (Issue 3, July 2015)</p> </li> </ul> </li> <li> <p>Ovid MEDLINE(R) In‐Process &amp; Other Non‐Indexed Citations and Ovid MEDLINE(R) (1946 to 27 October 2015) </p> </li> <li> <p>PubMed (segments not available on Ovid) (27 October 2015)</p> </li> <li> <p>EMBASE (1974 to 26 October 2015)</p> </li> <li> <p>LILACS (23 October 2015)</p> </li> <li> <p>CINAHL (27 October 2015)</p> </li> <li> <p>ClinicalTrials.gov (<a href="http://www.clinicaltrials.gov" target="_blank">http://www.clinicaltrials.gov</a>, 27 October 2015) </p> </li> <li> <p>WHO ICTRP Search Portal (<a href="http://apps.who.int/trialsearch/" target="_blank">http://apps.who.int/trialsearch/</a>) (27 October 2015): </p> <ul id="CD011281-list-0010"> <li> <p>Australian New Zealand Clinical Trials Registry (19 October 2015)</p> </li> <li> <p>Chinese Clinical Trial Registry (19 October 2015)</p> </li> <li> <p>ClinicalTrials.gov (19 October 2015)</p> </li> <li> <p>EU Clinical Trials Register (EU‐CTR) (19 October 2015)</p> </li> <li> <p>ISRCTN (19 October 2015)</p> </li> <li> <p>The Netherlands National Trial Register (19 October 2015)</p> </li> <li> <p>Brazilian Clinical Trials Registry (ReBec) (13 October 2015)</p> </li> <li> <p>Clinical Trials Registry ‐ India (13 October 2015)</p> </li> <li> <p>Clinical Research Information Service ‐ Republic of Korea (13 October 2015)</p> </li> <li> <p>Cuban Public Registry of Clinical Trials (13 October 2015)</p> </li> <li> <p>German Clinical Trials Register (13 October 2015)</p> </li> <li> <p>Iranian Registry of Clinical Trials (4 August 2015)</p> </li> <li> <p>Japan Primary Registries Network (19 October 2015)</p> </li> <li> <p>Pan African Clinical Trial Registry (13 October 2015)</p> </li> <li> <p>Sri Lanka Clinical Trials Registry (13 October 2015)</p> </li> <li> <p>Thai Clinical Trials Register (TCTR) (13 October 2015)</p> </li> </ul> </li> </ul> </p> <p>We continuously applied a MEDLINE (via Ovid) email alert service to identify newly published studies using the same search strategy as described for MEDLINE (for details on search strategies see <a href="./appendices#CD011281-sec-0109">Appendix 1</a>). After supplying the final review draft for editorial approval, the Cochrane Metabolic and Endocrine Disorders Group performed a complete updated search on all databases available at the editorial office and sent the results to the review authors. Should we have identified new trials for inclusion, we evaluated these, incorporated the findings into our review, and resubmitted another review draft (<a href="./references#CD011281-bbs2-0030" title="BellerEM , ChenJK , WangUL , GlasziouPP . Are systematic reviews up‐to‐date at the time of publication?. Systematic Reviews2013;2(1):36. ">Beller 2013</a>). </p> <p>We planned to evaluate any newly identified studies for inclusion, incorporate the findings into our review, and resubmit another review draft (<a href="./references#CD011281-bbs2-0030" title="BellerEM , ChenJK , WangUL , GlasziouPP . Are systematic reviews up‐to‐date at the time of publication?. Systematic Reviews2013;2(1):36. ">Beller 2013</a>). </p> <p>If we detected additional relevant key words during any of the electronic or other searches, we would have modified the electronic search strategies to incorporate these terms and document the changes to the search strategy. </p> </section> <section id="CD011281-sec-0051"> <h4 class="title">Searching other resources</h4> <p>We attempted to identify other potentially eligible trials or ancillary publications by searching the reference lists of retrieved included trials, (systematic) reviews, meta‐analyses, and health technology assessment reports. </p> </section> </section> <section id="CD011281-sec-0052"> <h3 class="title" id="CD011281-sec-0052">Data collection and analysis</h3> <section id="CD011281-sec-0053"> <h4 class="title">Selection of studies</h4> <p>Two review authors (CAC, LCL) independently reviewed the abstract, title, or both, of every record retrieved in order to determine which trials should be assessed further. We investigated all potentially relevant articles as full text. We resolved any discrepancies through consensus or recourse to a third review author (NDF). If resolution of a disagreement was not possible, we planned to add the article to those 'awaiting assessment', and we would have contacted study authors for clarification. We have presented an adapted Preferred Reporting Items for Systematic Reviews and Meta‐Analyses (PRISMA) flow diagram showing the process of trial selection (<a href="./references#CD011281-bbs2-0049" title="LiberatiA , AltmanDG , TetzlaffJ , MulrowC , GøtzschePC , IoannidisJPA , et al. The PRISMA statement for reporting systematic and meta‐analyses of studies that evaluate interventions: explanation and elaboration. PLoS Medicine2009;6(7):1‐28. [DOI: 10.1371/journal.pmed.1000100] ">Liberati 2009</a>). </p> </section> <section id="CD011281-sec-0054"> <h4 class="title">Data extraction and management</h4> <p>For trials that fulfilled our inclusion criteria, two review authors (CAC, LCL) independently abstracted relevant population and intervention characteristics using standard data extraction templates (for details see <a href="./references#CD011281-sec-0129" title="">Characteristics of included studies</a>; <a href="#CD011281-tbl-0003">Table 1</a>; <a href="./appendices#CD011281-sec-0110">Appendix 2</a>; <a href="./appendices#CD011281-sec-0111">Appendix 3</a>; <a href="./appendices#CD011281-sec-0112">Appendix 4</a>; <a href="./appendices#CD011281-sec-0113">Appendix 5;</a><a href="./appendices#CD011281-sec-0114">Appendix 6</a>; <a href="./appendices#CD011281-sec-0115">Appendix 7</a>; <a href="./appendices#CD011281-sec-0116">Appendix 8</a>; <a href="./appendices#CD011281-sec-0117">Appendix 9</a>; <a href="./appendices#CD011281-sec-0118">Appendix 10</a>; <a href="./appendices#CD011281-sec-0119">Appendix 11</a>; <a href="./appendices#CD011281-sec-0120">Appendix 12</a>), with any disagreements to be resolved by discussion, or, if required, by a third review author (NDF). </p> <div class="table" id="CD011281-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sample size<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screened/eligible<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analysed<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Finishing trial<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised finishing trial<br/> [%]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up time<sup>b</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Umpierrez 2004a</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Arbitrary estimation of a difference between groups of ≥ 5 hours to determine ketoacidosis as being clinically important; a sample size of 20 participants was needed in each group to provide a power of 0.93, given an alpha level of 0.05, a SD of 4, and a 1:1 inclusion ratio </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Mean hospital stay: 4 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Umpierrez 2004b</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: s.c. insulin aspart, every hour</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Arbitrary estimation of a difference between groups of ≥ 4 hours to determine ketoacidosis as being clinically significant. A sample size of 15 participants was needed in each group to provide a power of 0.81, given an alpha error of 0.05 and a SD of 3 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 3.4 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: s.c. insulin aspart, every 2 h</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 3.9 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 4.5 days</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Della Manna 2005</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Mean hospital stay: 2‐3 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Ersöz 2006</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b> Karoli 2011</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 6.6 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b><i>Grand total</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>110</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>110</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>91</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>91</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions and c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>201</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>201</i> </b> </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup>According to power calculation in study publication or report<br/> <sup>b</sup>Duration of intervention and/or follow‐up under randomised conditions until end of study </p> <p>‐ denotes not reported</p> <p>C: comparator; I: intervention; i.v.: intravenous; s.c.: subcutaneous; SD: standard deviation </p> </div> </div> <p>We have provided information including trial identifier about potentially relevant ongoing trials in Characteristics of ongoing studies and in <a href="./appendices#CD011281-sec-0113">Appendix 5</a> ('Matrix of study endpoints (publications and trial documents)'). We attempted to identify the protocol of each included trial, either in trials registers, publications of study designs, or both, and specified data in <a href="./appendices#CD011281-sec-0113">Appendix 5</a>. </p> <p>We emailed authors of included trials to enquire as to whether they would be willing to answer questions regarding their trials. <a href="./appendices#CD011281-sec-0121">Appendix 13</a> shows the results of this survey. We thereafter sought relevant missing information on the trial from the primary author(s) of the article, if required. </p> <p><b>Dealing with duplicate and companion publications</b> </p> <p>In the event of duplicate publications, companion documents, or multiple reports of a primary trial, we maximised yield of information by collating all available data and using the most complete data set aggregated across all known publications. Where unclear, the publication reporting the longest follow‐up associated with our primary or secondary outcomes obtained priority. We listed duplicate publications, companion documents or multiple reports of a primary trial as secondary references under the study ID of the included or excluded trial. </p> </section> <section id="CD011281-sec-0055"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors (CAC, NDF) independently assessed the risk of bias of each included trial. We resolved disagreements by consensus, or by consultation with a third review author (DGP). </p> <p>We assessed risk of bias using the tool of The Cochrane Collaboration (<a href="./references#CD011281-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>; <a href="./references#CD011281-bbs2-0038" title="HigginsJPT , AltmanDG , GøtzschePC , JüniP , MoherD , OxmanAD , et al. The Cochrane Collaboration's tool for assessing risk of bias in randomized trials. BMJ2011;343:d5928. ">Higgins 2011b</a>). We used the following criteria. </p> <p> <ul id="CD011281-list-0011"> <li> <p>Random sequence generation (selection bias).</p> </li> <li> <p>Allocation concealment (selection bias).</p> </li> <li> <p>Blinding of participants and personnel (performance bias).</p> </li> <li> <p>Blinding of outcome assessment (detection bias).</p> </li> <li> <p>Incomplete outcome data (attrition bias).</p> </li> <li> <p>Selective reporting (reporting bias).</p> </li> <li> <p>Other potential sources of bias.</p> </li> </ul> </p> <p>We judged 'Risk of bias' criteria as 'low risk', 'high risk', or 'unclear risk' and evaluated individual bias items as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011281-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). We have presented a 'Risk of bias' graph and a 'Risk of bias summary'. We assessed the impact of individual bias domains on trial results at the endpoint and trial levels. In case of high risk of selection bias, we would have marked all endpoints investigated in the associated trial as 'high risk'. </p> <p>For performance bias (blinding of participants and personnel) and detection bias (blinding of outcome assessors), we evaluated the risk of bias separately for each outcome (<a href="./references#CD011281-bbs2-0042" title="HróbjartssonA , ThomsenAS , EmanuelssonF , TendalB , HildenJ , BoutronI , et al. Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors. Canadian Medical Association Journal2013;185(4):E201‐11. ">Hróbjartsson 2013</a>). We noted whether outcomes were measured subjectively or objectively, for example if body weight was measured by participants or trial personnel. </p> <p>We considered the implications of missing outcome data from individual participants per outcome such as high drop‐out rates (for example above 15%) or disparate attrition rates (for example difference of 10% or more between trial arms). </p> <p>We assessed outcome reporting bias by integrating the results of 'Examination of outcome reporting bias' (<a href="./appendices#CD011281-sec-0114">Appendix 6</a>) and 'Matrix of study endpoints (publications and trial documents)' (<a href="./appendices#CD011281-sec-0113">Appendix 5</a>) (<a href="./references#CD011281-bbs2-0045" title="KirkhamJJ , DwanKM , AltmanDG , GambleC , DoddS , SmythR , et al. The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ2010;340:c365. [DOI: 10.1136/bmj.c365] ">Kirkham 2010</a>). This analysis formed the basis for the judgement of selective reporting (reporting bias). </p> <p>We defined the following endpoints as subjective outcome measures.</p> <p> <ul id="CD011281-list-0012"> <li> <p>Patient satisfaction.</p> </li> <li> <p>Hypoglycaemic episodes, depending on measurement.</p> </li> <li> <p>Adverse events other than hypoglycaemia, depending on measurement.</p> </li> </ul> </p> <p>We defined the following endpoints as objective outcome measures.</p> <p> <ul id="CD011281-list-0013"> <li> <p>Time to resolution of DKA.</p> </li> <li> <p>All‐cause mortality.</p> </li> <li> <p>Morbidity.</p> </li> <li> <p>Hypoglycaemic episodes, depending on measurement.</p> </li> <li> <p>Adverse events other than hypoglycaemia, depending on measurement.</p> </li> <li> <p>HbA1c.</p> </li> <li> <p>Socioeconomic effects.</p> </li> </ul> </p> </section> <section id="CD011281-sec-0056"> <h4 class="title">Measures of treatment effect</h4> <p>We expressed dichotomous data as odds ratios or risk ratios with 95% confidence intervals (CIs). We expressed continuous data as mean differences with 95% CIs. We planned to express time‐to‐event data as hazard ratios with 95% CIs. </p> </section> <section id="CD011281-sec-0057"> <h4 class="title">Unit of analysis issues</h4> <p>We took into account the level at which randomisation occurred, such as cross‐over trials, cluster‐randomised trials, and multiple observations for the same outcome. </p> </section> <section id="CD011281-sec-0058"> <h4 class="title">Dealing with missing data</h4> <p>We obtained missing data from authors, if feasible, and carefully evaluated important numerical data such as screened, randomised participants as well as intention‐to‐treat and as‐treated and per‐protocol populations. We investigated attrition rates, (e.g. drop‐outs, losses to follow‐up, withdrawals), and we will critically appraise issues concerning missing data and imputation methods (e.g. last observation carried forward (LOCF)). </p> <p>Where standard deviations for outcomes were not reported and we did not receive information from trial authors, we planned to impute these values by assuming the standard deviation of the missing outcome to be the average of the standard deviations from those studies where this information was reported. We wanted to investigate the impact of imputation on meta‐analyses by means of sensitivity analysis. </p> </section> <section id="CD011281-sec-0059"> <h4 class="title">Assessment of heterogeneity</h4> <p>In the event of substantial clinical or methodological heterogeneity, we did not report trial results as the pooled effect estimate in a meta‐analysis. </p> <p>We identified heterogeneity (inconsistency) through visual inspection of the forest plots and by using a standard Chi² test with a significance level of α = 0.1. In view of the low power of this test, we also considered the I² statistic, which quantifies inconsistency across trials to assess the impact of heterogeneity on the meta‐analysis (<a href="./references#CD011281-bbs2-0034" title="HigginsJPT , ThompsonSG . Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine2002;21:1539‐58. ">Higgins 2002</a>; <a href="./references#CD011281-bbs2-0035" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta‐analysis. BMJ2003;327:557‐60. ">Higgins 2003</a>); an I² statistic of 75% or more indicates a considerable level of heterogeneity (<a href="./references#CD011281-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> <p>Had we found heterogeneity, we would have attempted to determine possible reasons for it by examining individual trial and subgroup characteristics. </p> </section> <section id="CD011281-sec-0060"> <h4 class="title">Assessment of reporting biases</h4> <p>Had we included 10 trials or more investigating a particular outcome, we would have used funnel plots to assess small‐study effects. Several explanations can be offered for the asymmetry of a funnel plot, including true heterogeneity of effect with respect to trial size, poor methodological design (and hence bias of small trials), and publication bias. We therefore planned to interpret results carefully (<a href="./references#CD011281-bbs2-0063" title="SterneJA , SuttonAJ , IoannidisJP , TerrinN , JonesDR , LauJ , et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomized controlled trials. BMJ2011;343:d4002. ">Sterne 2011</a>). </p> </section> <section id="CD011281-sec-0061"> <h4 class="title">Data synthesis</h4> <p>Unless there was good evidence for homogeneous effects across studies, we primarily summarised low risk of bias data by means of a random‐effects model (<a href="./references#CD011281-bbs2-0066" title="WoodL , EggerM , GluudLL , SchulzKF , JuniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ2008;336(7644):601‐5. ">Wood 2008</a>). We interpreted random‐effects meta‐analyses with due consideration of the whole distribution of effects, ideally by presenting a prediction interval (<a href="./references#CD011281-bbs2-0036" title="HigginsJPT , ThompsonSG , SpiegelhalterDJ . A re‐evaluation of random‐effects meta‐analysis. Journal of the Royal Statistical Society: Series A (Statistics in Society)2009;172(1):137‐59. ">Higgins 2009</a>), which specifies a predicted range for the true treatment effect in an individual study (<a href="./references#CD011281-bbs2-0059" title="RileyRD , HigginsJP , DeeksJJ . Interpretation of random effects meta‐analyses. BMJ2011;342:d549. ">Riley 2011</a>). In addition, we performed statistical analyses according to the statistical guidelines presented in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011281-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>). </p> <p><b>Quality of evidence</b> </p> <p>We have presented the overall quality of the evidence for each outcome according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, which takes into account issues not only related to internal validity (risk of bias, inconsistency, imprecision, publication bias) but also to external validity, such as directness of results<i>.</i> Two review authors (CAC, NDF) independently rated the quality for each outcome. We have presented a summary of the evidence in 'Summary of findings' (SoF) tables, which provide key information about the best estimate of the magnitude of the effect, in relative terms and absolute differences for each relevant comparison of alternative management strategies, numbers of participants and trials addressing each important outcome, and the rating of the overall confidence in effect estimates for each outcome. We created the SoF tables based on the methods described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> by means of the table editor in Review Manager (RevMan), including <a href="./appendices#CD011281-sec-0120">Appendix 12</a> 'Checklist to aid consistency and reproducibility of GRADE assessments' to help with standardisation of the 'Summary of findings' tables (<a href="./references#CD011281-bbs2-0037" title="HigginsJPT , GreenS (editors) . Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011a</a>; <a href="./references#CD011281-bbs2-0054" title="MeaderN , KingK , LlewellynA , NormanG , BrownJ , RodgersM , et al. A checklist designed to aid consistency and reproducibility of GRADE assessments: development and pilot validation. Systematic Reviews2014;3:82. ">Meader 2014</a>; <a href="./references#CD011281-bbs2-0058" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). Alternatively, we used the GRADEproGDT software and present evidence profile tables as an appendix (GRADEproGDT 2015). We have presented results on the outcomes as described in the <a href="#CD011281-sec-0044">Types of outcome measures</a> section. If meta‐analysis was not possible, we presented results in a narrative form in the SoF table. </p> </section> <section id="CD011281-sec-0062"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We expected the following characteristics to introduce clinical heterogeneity, and planned to carried out subgroup analyses with investigation of interactions. </p> <p> <ul id="CD011281-list-0014"> <li> <p>Age.</p> </li> <li> <p>Pregnancy.</p> </li> <li> <p>Comorbidities.</p> </li> <li> <p>Precipitating factors (infection, poor adherence to diabetes treatment).</p> </li> <li> <p>Severity of DKA episode (mild, moderate, severe).</p> </li> </ul> </p> </section> <section id="CD011281-sec-0063"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to perform sensitivity analyses to explore the influence of the following factors (when applicable) on effect sizes by restricting the analysis to the following. </p> <p> <ul id="CD011281-list-0015"> <li> <p>Published trials.</p> </li> <li> <p>Taking into account risk of bias, as specified in the <a href="#CD011281-sec-0055">Assessment of risk of bias in included studies</a> section. </p> </li> <li> <p>Very long or large trials to establish the extent to which they dominate the results.</p> </li> <li> <p>Trials using the following filters: diagnostic criteria, imputation, language of publication, source of funding (industry versus other), or country. </p> </li> </ul> </p> <p>We also tested the robustness of the results by repeating the analysis using different measures of effect size (RR, OR, etc.) and different statistical models (fixed‐effect and random‐effects models). </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011281-sec-0064" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011281-sec-0064"></div> <section id="CD011281-sec-0065"> <h3 class="title">Description of studies</h3> <p>For a detailed description of the included trials, see <a href="./references#CD011281-sec-0129" title="">Characteristics of included studies</a>, <a href="./references#CD011281-sec-0130" title="">Characteristics of excluded studies,</a> and <a href="./references#CD011281-sec-0131" title="">Characteristics of studies awaiting classification</a>. </p> <section id="CD011281-sec-0066"> <h4 class="title">Results of the search</h4> <p>The electronic search strategies retrieved a total of 645 citations. After duplicates were excluded, two review authors (CAC, LCL) independently assessed the remaining titles and abstracts. We obtained the full text of 23 potentially relevant trials, seven of which we deemed potentially appropriate for inclusion in the analysis. Of these, two trials are awaiting classification, one trial was published as an abstract only, and another trial was registered in ClinicalTrials.gov with the status "This study has been completed", but no trial results were posted and no publication is available. We have provided information about these trials in <a href="./references#CD011281-sec-0131" title="">Characteristics of studies awaiting classification</a>. </p> <p>We have provided an adapted PRISMA flowchart of study selection, see <a href="#CD011281-fig-0001">Figure 1</a>. </p> <div class="figure" id="CD011281-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD011281-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> </section> <section id="CD011281-sec-0067"> <h4 class="title">Included studies</h4> <p>For a detailed description of the included studies, see <a href="./references#CD011281-sec-0129" title="">Characteristics of included studies</a>. The following is a succinct overview. </p> <p><b>Source of data</b> </p> <p>A total of five trials (five publications) met the inclusion criteria. All five included trials were published as peer‐reviewed original articles. All articles were published in English. We found no eligible trials from before the year 2004. </p> <p><b>Comparisons</b> </p> <p>All five included trials investigated the effects of a subcutaneous rapid‐acting insulin analogues compared with intravenous regular insulin. Four trials used lispro (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>), and one used aspart as a rapid acting insulin analogue (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). No trial applied glulisine. </p> <p><b>Overview of study populations</b> </p> <p>The included trials evaluated a total of 201 participants, of which 110 received a subcutaneous rapid‐acting insulin analogue and 91 received intravenous regular insulin. All randomised participants finished their assigned treatment. </p> <p><b>Study design</b> </p> <p>All included randomised controlled trials were of a parallel design and were performed in a single study centre. All trials compared a subcutaneous rapid‐acting insulin analogue with intravenous regular insulin in an open‐label fashion until resolution of the DKA episode. No trials specified blinding of outcome assessors. Trials were published from 2004 to 2011. Two trials were partly or entirely sponsored by the pharmaceutical industry (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). </p> <p><b>Settings</b> </p> <p>Trials were conducted in the USA (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>), Brazil (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>), Turkey (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>), and India (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>) (see <a href="./references#CD011281-sec-0129" title="">Characteristics of included studies</a> for details). In the US and Brazilian trials, participants were treated with subcutaneous insulin managed in regular medicine wards, in <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a> and <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>, or in the emergency department, in <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>, and the participants treated with intravenous insulin were managed in the intensive care unit (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Two trials stated that the participants were managed in the emergency department (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>), and the Turkish trial did not provide details about the setting (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>). </p> <p><b>Participants</b> </p> <p>A total of 201 participants were randomised and exposed to trial insulins in the included studies. All five trials recruited people who had a DKA episode (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). One trial included paediatric and adolescent participants (60 DKA episodes in 46 participants) with a median age of 11 years (range 3 to 17 years) (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>); the other trials included either type 1 or type 2 diabetic adults with a DKA episode (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). No trial specified the number of participants or percentages of participants with either type of diabetes. Three trials reported duration of diabetes (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>); mean duration of diabetes in these trials ranged between 3.9 and 6.9 years. The mean age of participants ranged between 34 and 49 years in the trials with adults only (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Sixty per cent of participants came from low‐ to middle‐income countries, and 27% to 76% were female. In one of the US trials, around 77% of participants were African American (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>). The other trials did not specify ethnic groups. </p> <p>Four of the five trials reported a precipitating cause of the DKA episode (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Poor compliance with insulin therapy was the most common precipitating cause (54%). Other precipitating causes reported were infections (31%) and new‐onset diabetes (15%). Two trials reported HbA1c at baseline (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Mean HbA1c at baseline in these trials ranged between 11.4% and 13.9%. </p> <p>All trials listed persistent hypotension as an exclusion criterion, but only the US trials clearly defined this (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Three trials excluded people with acute myocardial ischaemia, end‐stage renal disease, anasarca, and pregnancy (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Two trials excluded people with dementia (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>), heart failure (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>), and with American Diabetes Association (ADA) criteria for severe DKA (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>). Other criteria used for excluding participants were surgery, use of glucocorticoid or immunosuppressive agents (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>), and the presence of hepatic failure (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). </p> <p><b>Diagnosis</b> </p> <p>All trials specified diagnostic criteria for entry into the study. These criteria were consistent with the ADA criteria for mild or moderate DKA (<a href="./references#CD011281-bbs2-0025" title="American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care2004;27(Suppl 1):S94‐102. ">ADA 2004</a>). None of the included trials explicitly reported diagnostic criteria for diabetes mellitus. </p> <p><b>Interventions</b> </p> <p>None of the included trials reported treatment before the DKA episode. All of the trials compared subcutaneous rapid‐acting insulin analogue injections every one to two hours with continuous intravenous infusions of regular insulin. Duration of interventions ranged from DKA diagnosis to DKA resolution. </p> <p>Intravenous regular insulin regimens varied slightly across the trials. In three trials, the intravenous regular insulin bolus was 0.1 IU/kg, followed by continuous infusion given at 0.1 IU/kg/h until blood glucose decreased to &lt; 250 mg/dL, and then continued at a lower dose (0.05 IU/kg/h until resolution of DKA) (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a> used a slightly higher bolus dose of intravenous regular insulin of 0.15 IU/kg/h followed by “standard” intravenous regular insulin infusion. In the paediatric trial (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>), no bolus was used, and intravenous regular insulin infusion was given at 0.1 IU/kg/h until blood glucose decreased to &lt; 250 mg/dL; thereafter 0.15 IU/kg regular insulin was given subcutaneously 30 minutes before stopping the intravenous line. </p> <p>Subcutaneous rapid‐acting insulin analogues injections varied across studies. Four trials used lispro at given dosages: injection regimens were either 0.15 IU every two hours without bolus (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>), or 0.075 IU/kg every hour, preceded by a bolus injection of intravenous regular insulin (0.15 IU/kg) (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>), or 0.1 IU/kg every hour, preceded by an initial subcutaneous bolus of insulin lispro (0.3 IU/kg) (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>), or initial subcutaneous bolus of insulin lispro (0.3 IU/kg), followed by 0.2 IU/kg one hour later and then 0.2 IU/kg every two hours (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>). One trial used insulin aspart; subcutaneous insulin aspart was given as an initial dose of 0.3 IU/kg, followed by either 0.1 IU/kg every hour (group 1), or 0.2 IU/kg one hour later and every two hours (group 2) (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). In one trial, when capillary blood glucose levels neared 250 mg/dL, insulin lispro was administered every four hours for the next 24 hours (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>). </p> <p><b>Concomitant interventions</b> </p> <p>Fluid replacement protocols were similar in all included trials. This was largely in agreement with guideline recommendations (<a href="./references#CD011281-bbs2-0025" title="American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care2004;27(Suppl 1):S94‐102. ">ADA 2004</a>). Isotonic (0.9%) saline was infused at a rate of 10 to 20 mL/kg/h or 500 to 1000 mL/h for the initial one to two hours. Subsequent fluid replacement was adapted depending on the participant’s overall status and blood glucose levels until resolution of DKA. Potassium replacement was also in agreement with guideline recommendations (<a href="./references#CD011281-bbs2-0025" title="American Diabetes Association. Hyperglycemic crises in diabetes. Diabetes Care2004;27(Suppl 1):S94‐102. ">ADA 2004</a>). </p> <p><b>Outcomes</b> </p> <p>Three trials did not explicitly specify a primary outcome (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>). Four trials defined DKA by venous pH criteria (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>), and one trial by arterial pH (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>). Four trials used a serum bicarbonate criterion &gt; 18 mmol/L as an endpoint (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). The paediatric trial used a serum bicarbonate criterion &gt; 15 mmol/L (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>). Notably, only one trial clearly stated blood glucose levels &lt; 200 mg/dL as an endpoint (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>). </p> <p>All trials reported data on adverse events in the form of hypoglycaemic episodes during therapy. Four trials defined the endpoint for this outcome as a plasma glucose ≤ 60 mg/dL (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). In the trial by <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>, the outcome measure of hypoglycaemia was not defined. All five trials reported on in‐hospital mortality. Three trials reported length of hospital stay (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). The paediatric trial investigated morbidity in the form of cases of cerebral oedema (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>), and <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a> described venous thrombosis, adult respiratory distress syndrome, and hyperchloraemic acidosis events. One trial investigated total costs, measured as data on hospital charges (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>). No trial reported on patient satisfaction, adverse events other than hypoglycaemia, and change of HbA1c from baseline. </p> </section> <section id="CD011281-sec-0068"> <h4 class="title">Excluded studies</h4> <p>We excluded 16 trials after evaluation of the full publication. We have provided reasons for exclusion of studies in <a href="./references#CD011281-sec-0130" title="">Characteristics of excluded studies</a>. The main reasons for exclusion were inappropriate interventions and non‐randomised study design. </p> </section> </section> <section id="CD011281-sec-0069"> <h3 class="title">Risk of bias in included studies</h3> <p>For details on risk of bias of included trials, see <a href="./references#CD011281-sec-0129" title="">Characteristics of included studies</a>. </p> <p>For an overview of review authors' judgements about each risk of bias item for individual trials and across all trials, see <a href="#CD011281-fig-0002">Figure 2</a> and <a href="#CD011281-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD011281-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials)." data-id="CD011281-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials). </p> </div> </div> </div> <div class="figure" id="CD011281-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not measure that particular outcome)." data-id="CD011281-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not measure that particular outcome). </p> </div> </div> </div> <section id="CD011281-sec-0070"> <h4 class="title">Allocation</h4> <p>Reporting on the methods of randomisation and allocation concealment was poor in most of the trials. All trials were described as randomised, however the method of randomisation was adequately described in only two trials (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). None of the included trials described allocation concealment. </p> </section> <section id="CD011281-sec-0071"> <h4 class="title">Blinding</h4> <p>The stated method of blinding was open in all five trials. No trial described blinding of outcome assessors. Given the nature of the interventions, participant and personnel blinding was not appropriate. However, this implied a high risk of performance bias for the outcome measure time to resolution of DKA. </p> </section> <section id="CD011281-sec-0072"> <h4 class="title">Incomplete outcome data</h4> <p>All five trials reported having complete data for all included participants.</p> </section> <section id="CD011281-sec-0073"> <h4 class="title">Selective reporting</h4> <p>No study protocol was available for the included trials. Reporting bias was unclear for two trials due to unclear reporting of outcome data for time to resolution of DKA (<a href="./appendices#CD011281-sec-0114">Appendix 6</a>) (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>). </p> </section> <section id="CD011281-sec-0074"> <h4 class="title">Other potential sources of bias</h4> <p>Two publications reported commercial funding (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>), a source of possible sponsor bias. </p> </section> </section> <section id="CD011281-sec-0075"> <h3 class="title" id="CD011281-sec-0075">Effects of interventions</h3> <p>See: <a href="./full#CD011281-tbl-0001"><b>Summary of findings for the main comparison</b> Subcutaneous insulin lispro versus intravenous regular insulin for diabetic ketoacidosis</a>; <a href="./full#CD011281-tbl-0002"><b>Summary of findings 2</b> Subcutaneous insulin aspart versus intravenous regular insulin for diabetic ketoacidosis</a> </p> <section id="CD011281-sec-0076"> <h4 class="title">Baseline characteristics</h4> <p>For details of baseline characteristics, see <a href="./appendices#CD011281-sec-0111">Appendix 3</a> and <a href="./appendices#CD011281-sec-0112">Appendix 4</a>. </p> </section> <section id="CD011281-sec-0077"> <h4 class="title">Subcutaneous rapid‐acting insulin analogues versus intravenous infusion of regular insulin </h4> <p><a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a> was a three‐arm trial investigating intravenous regular insulin versus subcutaneous insulin aspart, given in doses one or two hours apart. In order to avoid a unit of analysis error, we used the one‐hour group for all meta‐analyses. </p> <section id="CD011281-sec-0078"> <h5 class="title">Primary outcomes</h5> <section id="CD011281-sec-0079"> <h6 class="title">Time to resolution of DKA</h6> <section id="CD011281-sec-0080"> <p><b>Lispro versus regular insulin (adults)</b></p> <p>Two trials compared subcutaneous insulin lispro with intravenous regular insulin in adults with DKA (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>). Meta‐analysis showed the following differences between the two groups: mean difference (MD) 0.2 h (95% confidence interval (CI) ‐1.7 to 2.1); P = 0.81; 90 participants; 2 trials; very low‐quality evidence; <a href="./references#CD011281-fig-0004" title="">Analysis 1.1</a>. There was a high risk of performance bias and an unclear risk of detection bias for both included trials (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>). </p> </section> <section id="CD011281-sec-0081"> <p><b>Lispro versus regular insulin (children)</b></p> <p>One trial including 60 children compared subcutaneous insulin lispro with intravenous regular insulin (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>). In both groups, the time to reach a glucose level of 250 mg/dL or less was approximately six hours. However, metabolic acidosis and ketosis took longer to resolve in the subcutaneous insulin lispro group (for intravenous regular insulin the time was six hours after capillary glucose ≤ 250 mg/dL, and for subcutaneous insulin lispro this occurred "in the next 6‐h interval" (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>)). The trial authors concluded that glycaemic control worsened when insulin lispro was spaced to every four hours, indicating that this was time was too long to maintain the insulin analogue action. In addition, children receiving insulin lispro were more likely to receive bicarbonate therapy. There was a high risk of performance bias, an unclear risk of detection bias, and an unclear risk of reporting bias for this included trial (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>). </p> </section> <section id="CD011281-sec-0082"> <p><b>Aspart versus regular insulin</b></p> <p>One trial compared subcutaneous insulin aspart with intravenous regular insulin in an adult population (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). There was the following difference between the two groups: MD ‐1 h (95% CI ‐3.2 to 1.2); P = 0.36; 30 participants; 1 trial; very low‐quality evidence; <a href="./references#CD011281-fig-0008" title="">Analysis 2.1</a>. There was a high risk of performance bias and an unclear risk of detection bias for this included trial (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). </p> </section> </section> <section id="CD011281-sec-0083"> <h6 class="title">All‐cause mortality</h6> <p>All five included trials reported that there were no deaths (4 trials with 156 participants evaluating insulin lispro; moderate‐quality evidence; <a href="./references#CD011281-fig-0004" title="">Analysis 1.1</a>, and 1 trial with 45 participants evaluating insulin aspart (two different insulin aspart schemes in 15 participants each); low‐quality evidence; <a href="./references#CD011281-fig-0008" title="">Analysis 2.1</a>). However, no trial was adequately powered to investigate all‐cause mortality. There was an overall low risk of bias for this outcome measure. </p> </section> <section id="CD011281-sec-0084"> <h6 class="title">Hypoglycaemic episodes</h6> <p>Information on hypoglycaemia was available from all included trials. Hypoglycaemia was mostly defined as a blood glucose level lower than 60 mg/dL (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). One trial did not provide a definition of hypoglycaemia (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>). </p> <section id="CD011281-sec-0085"> <p><b>Lispro versus regular insulin</b></p> <p>Four trials reported hypoglycaemic episodes (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>; <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Comparison of insulin lispro versus regular insulin showed a risk ratio (RR) 0.59 (95% CI 0.23 to 1.52); P = 0.28; 156 participants; 4 trials; low‐quality evidence; <a href="./references#CD011281-fig-0006" title="">Analysis 1.3</a>. There was a high risk of performance bias and an unclear risk of detection bias for all included trials. </p> </section> <section id="CD011281-sec-0086"> <p><b>Aspart versus regular insulin</b></p> <p>One trial including 45 participants compared subcutaneous insulin aspart with intravenous regular insulin in an adult population (<a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Insulin aspart versus regular insulin did not show marked differences in the number of hypoglycaemic episodes (1/15 in the insulin aspart given every hour group; 1/15 in the insulin aspart given every two hours group; and 1/15 in the regular insulin group. RR comparing one of the two insulin aspart groups versus the regular insulin group was 1.00 (95% CI 0.07 to 14.55); P = 1.00; 30 participants; 1 trial; low‐quality evidence; <a href="./references#CD011281-fig-0010" title="">Analysis 2.3</a>. There was a high risk of performance bias and an unclear risk of detection bias for the included trial. </p> </section> </section> </section> <section id="CD011281-sec-0087"> <h5 class="title">Secondary outcomes</h5> <section id="CD011281-sec-0088"> <h6 class="title">Morbidity</h6> <p>Two trials investigating the effects of insulin lispro versus regular insulin reported some data on morbidity related to the sequelae of DKA. One paediatric trial reported morbidity in the form of cerebral oedema (<a href="./references#CD011281-bbs2-0001" title="Della MannaT , SteinmetzL , CamposPR , FarhatSC , SchvartsmanC , KupermanH , et al. Subcutaneous use of a fast‐acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis. Diabetes Care2005;28(8):1856‐61. ">Della Manna 2005</a>). There were no cases of cerebral oedema, and no child had to be treated with mannitol. <a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a> reported that none of the participants in either group developed complications such as venous thrombosis, adult respiratory distress syndrome, or hyperchloraemic acidosis. </p> </section> <section id="CD011281-sec-0089"> <h6 class="title">Adverse events other than hypoglycaemia</h6> <p>No trials reported adverse events other than hypoglycaemia.</p> </section> <section id="CD011281-sec-0090"> <h6 class="title">Patient satisfaction</h6> <p>No trial reported on patient satisfaction.</p> </section> <section id="CD011281-sec-0091"> <h6 class="title">HbA1c</h6> <p>HbA1c values were available in two trials for verification of metabolic control (<a href="./references#CD011281-bbs2-0002" title="ErsözHO , UkincK , KöseM , EremC , GunduzA , HacihasanogluAB , et al. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients. International Journal of Clinical Practice2006;60(4):429‐33. ">Ersöz 2006</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). However, the differences in change of HbA1c from baseline to study endpoint were not reported. </p> </section> <section id="CD011281-sec-0092"> <h6 class="title">Socioeconomic effects</h6> <p>Three of the trials performed in adults reported length of hospital stay (<a href="./references#CD011281-bbs2-0003" title="KaroliR , FatimaJ , SalmanT , SandhuS , ShankarR . Managing diabetic ketoacidosis in non‐intensive care unit setting: Role of insulin analogs. Indian Journal of Pharmacology2011;43(4):398‐401. ">Karoli 2011</a>; <a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>; <a href="./references#CD011281-bbs2-0005" title="UmpierrezGE , CuervoR , KarabellA , LatifK , FreireAX , KitabchiAE . Treatment of diabetic ketoacidosis with subcutaneous insulin aspart. Diabetes Care2004;27(8):1873‐8. ">Umpierrez 2004b</a>). Comparing subcutaneous insulin lispro with intravenous regular insulin resulted in a MD of ‐0.4 days (95% CI ‐1 to 0.2); P = 0.22; 90 participants; 2 trials; low‐quality evidence; (<a href="./references#CD011281-fig-0007" title="">Analysis 1.4</a>) and between subcutaneous insulin aspart and intravenous regular insulin: MD ‐1.1 day (95% CI ‐3.3 to 1.1); P = 0.32; 30 participants; 1 trial; low‐quality evidence (<a href="./references#CD011281-fig-0011" title="">Analysis 2.4</a>). </p> <p>One study addressed costs (<a href="./references#CD011281-bbs2-0004" title="UmpierrezGE , LatifK , StoeverJ , CuervoR , ParkL , FreireAX , et al. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. American Journal of Medicine2004;117(5):291‐6. ">Umpierrez 2004a</a>). The study authors calculated that DKA treatment with subcutaneous insulin lispro in the non‐intensive care unit setting was associated with 39% lower hospitalisation charges compared with regular insulin treatment in the intensive care unit (USD 8801 (SD USD 5549) versus USD 14,429 (SD USD 5243). </p> </section> </section> </section> <section id="CD011281-sec-0093"> <h4 class="title">Subgroup analyses</h4> <p>We did not perform subgroup analyses because there were not enough studies to estimate effects in various subgroups. </p> </section> <section id="CD011281-sec-0094"> <h4 class="title">Sensitivity analyses</h4> <p>We could not perform preplanned analyses excluding unpublished trials because we included only published studies in this review. We were unable to perform sensitivity analyses with regard to risk of bias because all studies were of high or unclear risk of bias in various domains. </p> </section> <section id="CD011281-sec-0095"> <h4 class="title">Assessment of reporting bias</h4> <p>We did not draw funnel plots due to limited number of studies (n = 5).</p> </section> <section id="CD011281-sec-0096"> <h4 class="title">Ongoing studies</h4> <p>We did not identify ongoing randomised controlled trials.</p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011281-sec-0097" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011281-sec-0097">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011281-sec-0151">Español</a> </li> </nav> </div> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011281-sec-0097"></div> <section id="CD011281-sec-0098"> <h3 class="title" id="CD011281-sec-0098">Summary of main results</h3> <p>This systematic review analysed the evidence from all published randomised controlled trials (RCTs) of subcutaneous rapid‐acting insulin analogues in the treatment of diabetic ketoacidosis (DKA). We included five trials with a total of 201 participants in this review. The results of our review suggest that there is no substantial difference in the time to resolution of DKA between the subcutaneous rapid‐acting insulin analogues lispro or aspart and intravenous regular insulin in adult participants. In the one included trial that assessed the effects of insulin lispro in children and adolescents with DKA, the resolution of acidaemia took longer as compared to intravenous regular insulin; the authors attributed this slower resolution to the increased interval of injections at every four hours after the initial decline of blood glucose to less than 250 mg/dL. </p> <p>In terms of hypoglycaemia and length of hospital stay, the results obtained with subcutaneous rapid‐acting insulin analogues and regular insulin were comparable in both adults and children. No deaths occurred. Data on morbidity and socioeconomic effects were limited. None of the trials reported on adverse events other than hypoglycaemia, patient satisfaction, or glycosylated haemoglobin A1c. </p> </section> <section id="CD011281-sec-0099"> <h3 class="title" id="CD011281-sec-0099">Overall completeness and applicability of evidence</h3> <p>The trials analysed in this review were conducted in four different countries, three of which could be considered as low‐ or middle‐income countries. Notably, most participants representing the high‐income Western region were of African‐American ethnicity. Younger diabetic participants and children were underrepresented in our trial cohorts. Based on the inclusion criteria of the analysed trials, the results are most relevant to adults with a mild or moderate DKA episode due to poor compliance with diabetes therapy. This may reflect poor 'health literacy' and lack of comprehension of treatment plans, factors associated with socioeconomic deprivation in low‐ or middle‐income countries. Regarding the interventions, rapid‐acting insulin analogues like insulin lispro and insulin aspart are widely available for use in daily clinical practice. </p> </section> <section id="CD011281-sec-0100"> <h3 class="title" id="CD011281-sec-0100">Quality of the evidence</h3> <p>The risk of bias across several domains was unclear for the majority of included studies. This was due mainly to there being insufficient information to permit judgement of either a low or high risk of bias, despite attempts to contact the trial authors. According to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, the quality of the evidence was low or very low for most clinically important outcomes (see <a href="./full#CD011281-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD011281-tbl-0002">summary of findings Table 2</a>). The available data were thus too few and inconsistent to provide firm evidence about the effects of subcutaneous rapid‐acting insulin analogues in people with DKA. </p> </section> <section id="CD011281-sec-0101"> <h3 class="title" id="CD011281-sec-0101">Potential biases in the review process</h3> <p>We conducted our review according to the previously published protocol. Two review authors independently assessed all citations identified by our electronic search strategies. Likewise, two review authors conducted 'Risk of bias' assessment and data collection. There were no conflicts of interests. </p> <p>We believe that our search for RCTs has been comprehensive. However, we cannot exclude the possibility that studies with negative findings remain unpublished. Also, we did not systematically search the grey literature. </p> </section> <section id="CD011281-sec-0102"> <h3 class="title" id="CD011281-sec-0102">Agreements and disagreements with other studies or reviews</h3> <p>Our systematic review on subcutaneous rapid‐acting insulin analogues for DKA is in agreement with previously published reviews, <a href="./references#CD011281-bbs2-0053" title="MazerM , ChenE . Is subcutaneous administration of rapid‐acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?. Annals of Emergency Medicine2009;53(2):259‐63. ">Mazer 2009</a> and <a href="./references#CD011281-bbs2-0019" title="VincentM , NobécourtE . Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies. Diabetes &amp; Metabolism2013;39(4):299‐305. ">Vincent 2013</a>, and current guidelines on the management of a hyperglycaemic crisis in adults with diabetes; treatment with subcutaneous rapid‐acting insulin analogues (lispro and aspart) appears as an alternative to the use of intravenous regular insulin in the treatment of mild and moderate DKA (<a href="./references#CD011281-bbs2-0047" title="KitabchiAE , UmpierrezGE , MilesJM , FisherJN . Hyperglycemic crises in adult patients with diabetes. Diabetes Care2009;32(7):1335‐43. ">Kitabchi 2009</a>). </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011281-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD011281-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials)." data-id="CD011281-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included trials (blank cells indicate that the particular outcome was not measured in some trials). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not measure that particular outcome)." data-id="CD011281-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included trial (blank cells indicate that the trial did not measure that particular outcome). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Insulin lispro versus regular insulin, Outcome 1 Time to resolution of diabetic ketoacidosis." data-id="CD011281-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Insulin lispro versus regular insulin, Outcome 1 Time to resolution of diabetic ketoacidosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Insulin lispro versus regular insulin, Outcome 2 All‐cause mortality." data-id="CD011281-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Insulin lispro versus regular insulin, Outcome 2 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Insulin lispro versus regular insulin, Outcome 3 Hypoglycaemic episodes." data-id="CD011281-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Insulin lispro versus regular insulin, Outcome 3 Hypoglycaemic episodes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Insulin lispro versus regular insulin, Outcome 4 Length of hospital stay." data-id="CD011281-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Insulin lispro versus regular insulin, Outcome 4 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Insulin aspart versus regular insulin, Outcome 1 Time to resolution of diabetic ketoacidosis." data-id="CD011281-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Insulin aspart versus regular insulin, Outcome 1 Time to resolution of diabetic ketoacidosis. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Insulin aspart versus regular insulin, Outcome 2 All‐cause mortality." data-id="CD011281-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Insulin aspart versus regular insulin, Outcome 2 All‐cause mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-002-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-002-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Insulin aspart versus regular insulin, Outcome 3 Hypoglycaemic episodes." data-id="CD011281-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2 Insulin aspart versus regular insulin, Outcome 3 Hypoglycaemic episodes.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011281-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/urn:x-wiley:14651858:media:CD011281:CD011281-CMP-002-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_t/tCD011281-CMP-002-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Insulin aspart versus regular insulin, Outcome 4 Length of hospital stay." data-id="CD011281-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2 Insulin aspart versus regular insulin, Outcome 4 Length of hospital stay.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/media/CDSR/CD011281/image_n/nCD011281-CMP-002-04.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011281-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Subcutaneous insulin lispro versus intravenous regular insulin for diabetic ketoacidosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Subcutaneous insulin lispro versus intravenous regular insulin for diabetic ketoacidosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient:</b> participants with diabetic ketoacidosis<br/> <b>Settings:</b> emergency department and critical care unit<br/> <b>Intervention:</b> subcutaneous insulin lispro versus intravenous regular insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intravenous regular insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Subcutaneous insulin lispro</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality (N)</b> </p> <p>Mean hospital stay: 2‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/> <b>moderate<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No deaths reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hypoglycaemic episodes (N)</b> </p> <p>Mean hospital stay: 2‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>118 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>70 per 1000</b> <br/> (27 to 180) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.59</b> <br/> (0.23 to 1.52) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>156 (4)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Comparable risk ratios for adults (4 trials) and children (1 trial)</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Morbidity (N)</b> </p> <p>Mean hospital stay: 2‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>96 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No cases of cerebral oedema, venous thrombosis, adult respiratory distress syndrome, hyperchloraemic acidosis </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events other than hypoglycaemic episodes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to resolution of diabetic ketoacidosis (h)</b> </p> <p>Mean hospital stay: 2‐4 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis across the intravenous regular insulin groups was 11 h </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis in the subcutaneous insulin lispro groups was <b>0.2 h higher</b> (1.7 h lower to 2.1 h higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Metabolic acidosis and ketosis took longer to resolve in the subcutaneous insulin lispro group in 1 trial (60 children); no exact data published </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Socioeconomic effects: length of hospital stay (days)</b> </p> <p>Mean hospital stay: 4‐7 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intravenous regular insulin groups ranged between 4 and 6.6 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the subcutaneous insulin lispro groups was <b>0.4 days shorter</b> (1 day shorter to 0.2 days longer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (2)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>d</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>US setting: treatment of diabetic ketoacidosis in a non–intensive care setting (step‐down unit or general medicine ward) was associated with a 39% lower hospitalisation charge than was treatment with intravenous regular insulin in the intensive care unit (USD 8801 (SD USD 5549) vs USD 14,429 (SD USD 5243); the average hospitalisation charges per day were USD 3981 (SD USD 1067) for participants treated in an intensive care unit compared with USD 2682 (SD USD 636) for those treated in a non–intensive care setting </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>h:</b> hours; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*Assumed risk was derived from the event rates in the comparator groups.<br/> <sup>a</sup>Downgraded by one level because of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>).<br/> <sup>b</sup>Downgraded by two levels because of risk of performance bias and serious imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>).<br/> <sup>c</sup>Downgraded by three levels because of risk of performance bias, serious risk of inconsistency, and serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>).<br/> <sup>d</sup>Downgraded by two levels because of serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Subcutaneous insulin lispro versus intravenous regular insulin for diabetic ketoacidosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD011281-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subcutaneous insulin aspart versus intravenous regular insulin for diabetic ketoacidosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Subcutaneous insulin aspart versus intravenous regular insulin for diabetic ketoacidosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient:</b> participants with diabetic ketoacidosis<br/> <b>Settings:</b> general medicine ward and intensive care unit<br/> <b>Intervention:</b> subcutaneous insulin aspart versus intravenous regular insulin </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Illustrative comparative risks* (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>No of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Quality of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="3" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Assumed risk</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Corresponding risk</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Intravenous regular insulin</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b> Subcutaneous insulin aspart</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality (N)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No deaths reported</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Hypoglycaemic episodes (N)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>67 per 1000</b> <br/> (5 to 970) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>RR 1.00</b> <br/> (0.07 to 14.55) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>b</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Morbidity</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse events other than hypoglycaemic episodes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Time to resolution of diabetic ketoacidosis (h)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis across the intravenous regular insulin groups was 11 h </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean time to resolution of diabetic ketoacidosis in the subcutaneous insulin aspart group was <b>1 h lower</b> (3.2 h lower to 1.2 h higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/> <b>very low<sup>c</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Patient satisfaction</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>See comment</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not investigated</p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Socioeconomic effects: length of hospital stay (days)</b> </p> <p>Mean hospital stay: 3‐5 days</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the intravenous regular insulin group was 4.5 days </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean length of hospital stay in the subcutaneous insulin aspart group was <b>1.1 days shorter</b> (3.3 days shorter to 1.1 days longer) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> <b>low<sup>d</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>*The basis for the <b>assumed risk</b> (e.g. the median control group risk across studies) is provided in footnotes. The <b>corresponding risk</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <b>CI:</b> confidence interval; <b>h:</b> hours; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p>GRADE Working Group grades of evidence<br/> <b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/> <b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/> <b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/> <b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p>*Assumed risk was derived from the event rates in the comparator groups<br/> <sup>a</sup>Downgraded by two levels because of serious imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>)<br/> <sup>b</sup>Downgraded by two levels because of risk of performance bias and imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>)<br/> <sup>c</sup>Downgraded by three levels because of risk of performance bias and serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>)<br/> <sup>d</sup>Downgraded by two levels because of serious risk of imprecision (see <a href="./appendices#CD011281-sec-0120">Appendix 12</a>) </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Subcutaneous insulin aspart versus intravenous regular insulin for diabetic ketoacidosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011281-tbl-0003"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of study populations</span></div> <tbody> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Intervention(s) and comparator(s)</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Sample size<sup>a</sup> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Screened/eligible<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Analysed<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Finishing trial<br/> [N]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Randomised finishing trial<br/> [%]</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Follow‐up time<sup>b</sup> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Umpierrez 2004a</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Arbitrary estimation of a difference between groups of ≥ 5 hours to determine ketoacidosis as being clinically important; a sample size of 20 participants was needed in each group to provide a power of 0.93, given an alpha level of 0.05, a SD of 4, and a 1:1 inclusion ratio </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Mean hospital stay: 4 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>40</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="4" valign="top"> <p><b>Umpierrez 2004b</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I1: s.c. insulin aspart, every hour</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Arbitrary estimation of a difference between groups of ≥ 4 hours to determine ketoacidosis as being clinically significant. A sample size of 15 participants was needed in each group to provide a power of 0.81, given an alpha error of 0.05 and a SD of 3 </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 3.4 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I2: s.c. insulin aspart, every 2 h</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 3.9 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>15</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 4.5 days</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Della Manna 2005</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Mean hospital stay: 2‐3 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>21</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="3" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Ersöz 2006</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>‐</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p><b>total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>20</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b> Karoli 2011</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>I: s.c. insulin lispro</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 6 days</p> </td> </tr> <tr> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>C: i.v. regular insulin</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean hospital stay: 6.6 days</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b> total:</b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b><i>Grand total</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>110</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"></td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>110</i> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="3" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>91</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>91</i> </b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>All interventions and c</i> <i>omparators</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>201</i> </b> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b><i>201</i> </b> </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p><sup>a</sup>According to power calculation in study publication or report<br/> <sup>b</sup>Duration of intervention and/or follow‐up under randomised conditions until end of study </p> <p>‐ denotes not reported</p> <p>C: comparator; I: intervention; i.v.: intravenous; s.c.: subcutaneous; SD: standard deviation </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Overview of study populations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/full#CD011281-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011281-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Insulin lispro versus regular insulin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Time to resolution of diabetic ketoacidosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Std. Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.13 [‐0.64, 0.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>156</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.23, 1.52]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Adults</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>110</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.11, 3.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Children</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.18, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.38 [‐0.97, 0.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Insulin lispro versus regular insulin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011281-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Insulin aspart versus regular insulin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Time to resolution of diabetic ketoacidosis <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 All‐cause mortality <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Hypoglycaemic episodes <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Length of hospital stay <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Insulin aspart versus regular insulin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011281.pub2/references#CD011281-tbl-0005">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011281.pub2&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011281-note-0001">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011281-note-0004">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011281-note-0006">فارسی</a> </li> <li class="section-language"> <a class="" href="hr#CD011281-note-0003">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ru#CD011281-note-0002">Русский</a> </li> <li class="section-language"> <a class="" href="th#CD011281-note-0005">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011281-note-0013">简体中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011281\x2epub2"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011281\x2epub2"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011281\x2epub2"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011281\x2epub2\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011281\x2epub2"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=uQyIsxpV&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011281.pub2&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011281.pub2';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011281.pub2/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011281.pub2/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011281.pub2%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740726523011"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011281.pub2/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740726523015"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011281.pub2/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918e95acdeedf3c9',t:'MTc0MDcyNjUyMy4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 